Therapeutic Potential of Nitric Oxide Donors in Cancer: Focus on Angiogenesis

被引：4
|
作者：
Morbidelli, Lucia [1 ]
机构：
[1] Univ Siena, Dept Life Sci, Lab Pharmacol Angiogenesis & Microcirculat, Via A Moro 2, I-53100 Siena, Italy
来源：
CRITICAL REVIEWS IN ONCOGENESIS | 2016年 / 21卷 / 5-6期
关键词：
Angiogenesis; Apoptosis; NO donors; NO hybrids; Tumor growth;
D O I：
10.1615/CritRevOncog.2017021114
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
A new challenge to overcoming tumor resistance to conventional treatment is represented by the development of novel nitric oxide (NO) donors. It is now clear that while low doses of NO have proneoplastic properties, high doses exert antitumor/antiangiogenic activities through multiple mechanisms. This review focuses on the role of exogenous NO in cancer therapy and reports the state of the art regarding different NO-donating agents in cancer treatment, particularly in relation to angiogenesis inhibition.
引用
收藏
页码：447 / 458
页数：12
相关论文
共 50 条
  • [41] Anti-angiogenesis Potential of Phytochemicals for the Therapeutic Management of Tumors
    Munir, Samman
    Shah, Asad A.
    Shahid, Muhammad
    Ahmed, Muhammad S.
    Shahid, Aqsa
    Rajoka, Muhammad S. R.
    Akash, Muhammad S. H.
    Akram, Muhammad
    Khurshid, Mohsin
    CURRENT PHARMACEUTICAL DESIGN, 2020, 26 (02) : 265 - 278
  • [42] Angiogenesis and vasculogenic mimicry as therapeutic targets in ovarian cancer
    Lim, Dansaem
    Do, Yeojin
    Kwon, Byung Su
    Chang, Woochul
    Lee, Myeong-Sok
    Kim, Jongmin
    Cho, Jin Gu
    BMB REPORTS, 2020, 53 (06) : 291 - 298
  • [43] Nitric oxide:: properties and therapeutic use
    Barreto, Ricardo de L.
    Correia, Carlos Roque D.
    Muscara, Marcelo N.
    QUIMICA NOVA, 2005, 28 (06): : 1046 - 1054
  • [44] Angiogenesis as a potential target of pharmaconutrients in cancer therapy
    Granci, Virginie
    Dupertuis, Yves M.
    Pichard, Claude
    CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2010, 13 (04) : 417 - 422
  • [45] Therapeutic Potential of Luteolin on Cancer
    cetinkaya, Melisa
    Baran, Yusuf
    VACCINES, 2023, 11 (03)
  • [46] Therapeutic Potential of Apatinib Against Colorectal Cancer by Inhibiting VEGFR2-Mediated Angiogenesis and β-Catenin Signaling
    Cai, Xiaomin
    Wei, Bin
    Li, Lele
    Chen, Xiaofeng
    Yang, Jing
    Li, Xiaofei
    Jiang, Xiaozheng
    Lv, Mu
    Li, Mingyang
    Lin, Yumeng
    Xu, Qiang
    Guo, Wenjie
    Gu, Yanhong
    ONCOTARGETS AND THERAPY, 2020, 13 : 11031 - 11044
  • [47] Evaluation of nitric oxide donors impact on cisplatin resistance in various ovarian cancer cell lines
    Kielbik, Michal
    Szulc-Kielbik, Izabela
    Nowak, Marek
    Sulowska, Zofia
    Klink, Magdalena
    TOXICOLOGY IN VITRO, 2016, 36 : 26 - 37
  • [48] Novel endogenous angiogenesis inhibitors and their therapeutic potential
    Rao, Nithya
    Lee, Yu Fei
    Ge, Ruowen
    ACTA PHARMACOLOGICA SINICA, 2015, 36 (10) : 1177 - 1190
  • [49] Role of nitric oxide and its metabolites as potential markers in lung cancer
    Masri, Fares
    ANNALS OF THORACIC MEDICINE, 2010, 5 (03) : 123 - 127
  • [50] Axl as a potential therapeutic target in cancer: role of Axl in tumor growth, metastasis and angiogenesis
    Li, Y.
    Ye, X.
    Tan, C.
    Hongo, J-A
    Zha, J.
    Liu, J.
    Kallop, D.
    Ludlam, M. J. C.
    Pei, L.
    ONCOGENE, 2009, 28 (39) : 3442 - 3455
12345